• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Study: AI-Powered Solution Achieves High Accuracy for Detecting COVID-19 on CT

Share:

March 31, 2020

Highlights on this story:
  • New RADLogics research that validates the performance of an AI-powered CT image analysis solution that is designed to automatically and accurately detect COVID-19 (Coronavirus) and quantify the disease burden in affected patients.
  • The study found that the CT image analysis algorithm – developed from multiple international datasets – was able to differentiate 157 patients with and without COVID-19 with a 0.996 AUC (plus, 98.2 percent sensitivity and 92.2 percent specificity).
  • Although it is not recommended as a first-line test, non-contrast thoracic CT has been shown to be an effective tool in the detection, quantification, and follow-up of COVID-19.

RADLogics announced today new research that validates the performance of an AI-powered CT image analysis solution that is designed to automatically and accurately detect COVID-19 (Coronavirus) and quantify the disease burden in affected patients. To meet the growing worldwide pandemic, RADLogics also announced that it has rapidly deployed this new CT image analysis algorithm, which helps classify results for patients with COVID-19 per thoracic CT studies utilizing deep-learning image analysis.

Study Background

The study, led by Professor Hayit Greenspan from Tel Aviv University and RADLogics, in collaboration with Dr. Eliot Siegel of the University of Maryland School of Medicine in Baltimore, MD; and Dr. Adam Bernheim of the Icahn School of Medicine at Mount Sinai in New York, NY; found that the CT image analysis algorithm – developed from multiple international datasets – was able to differentiate 157 patients with and without COVID-19 with a 0.996 AUC (plus, 98.2 percent sensitivity and 92.2 percent specificity).

Analyzing Large Numbers of CT Studies for COVID-19

Although it is not recommended as a first-line test, non-contrast thoracic CT has been shown to be an effective tool in the detection, quantification, and follow-up of COVID-19. In addition to detecting and quantifying disease burden, RADLogics’ image analysis further outputs a suggested “Corona Score,” which measures the percentage of lung volume that is infected by the disease.

A consistent and reproducible method for rapidly screening and evaluating high volumes of thoracic CT imaging studies can assist healthcare systems through this pandemic by augmenting radiologists and acute care teams that could be overwhelmed with patients. Additionally, with a greater volume of patients who must be screened for coronavirus, earlier and more rapid detection of positive cases can help improve both the treatment of patients and containment of virus spread.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“This study validates our novel solution, which has been widely studied via multiple international datasets and a range of retrospective experiments to analyze the performance over time,” added Becker. “The conclusion was clear: our rapidly-developed AI-based image analysis can achieve high accuracy in detection of coronavirus as well as quantification and tracking of disease burden.”

Results of this study are available on https://arxiv.org/abs/2003.05037, and it has been submitted to the Radiology Society of North America (RSNA) for review and potential publication in Radiology: Artificial Intelligence. RADLogics is also expanding the initial study to a larger population.

To meet the growing worldwide pandemic, RADLogics also announced that it has rapidly deployed this new CT image analysis algorithm in China, Russia and Italy, and the company is rapidly scaling in other countries in response to the strong demand.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • NVIDIA Looks to Telehealth with Automatic Speech Recognition ToolNVIDIA Looks to Telehealth with Automatic Speech Recognition Tool
  • Thermo Fisher Scientific Inc.: Thermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings CorporationThermo Fisher Scientific Inc.: Thermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings Corporation
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries LtdTreprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Fitbit Begins Smartwatch Blood Pressure Tracking StudyFitbit Begins Smartwatch Blood Pressure Tracking Study
  • Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry PortfolioLuminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio
  • National Seating & Mobility Bolsters Presence in British Columbia, Canada with Multi-Site AcquisitionNational Seating & Mobility Bolsters Presence in British Columbia, Canada with Multi-Site Acquisition
  • Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening TestMainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
  • HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK CellsHebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications